ClinicalTrials.gg
RecruitingNCT07721311Updated Aug 20, 2026

Breastfeeding Education Integrated With Web Portal and Mobile Application-Supported Counseling

An interventional study of Intervention Group in Breastfeeding, Breastfeeding Attitudes and Breastfeeding Education, sponsored by Aydin Adnan Menderes University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by Aydin Adnan Menderes University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.

Planned enrollment
197th of 252
62 · median 80
Started
2026
with 32 others
No phase
251 of 274
65 open now
Primary completion
2027-02
later than 64 of 76 live
Registered
259th of 274
by date
Lead sponsor
7 of 274
Aydin Adnan Menderes University

Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 197th largest by planned enrollment of the 252 interventional ones, is one of 33 that started in 2026, is one of 251 with no phase, reaches primary completion later than 64 of the 76 other live ones, and was the 259th registered.

By phase

274 studies; the count open now beside each. This study's row is marked.

No phasethis study251 · 65 open
Observational22 · 3 open
Phase 41 · 0 open

By the year they started

First in 2011; this study’s year is marked. 33 started in 2026.

What they test

Size and results

Median enrollment 80 across the 252 interventional studies, 163 across the 22 observational. Of the 178 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 274 studies in Breast Feeding with a site in Turkey, or all of them as a file.
02

Study summary

Breastfeeding provides significant benefits for maternal and infant health; however, perceived insufficient milk supply is one of the most common factors associated with early breastfeeding discontinuation. Although the World Health Organization recommends exclusive breastfeeding for the first six months of life, breastfeeding continuation rates remain suboptimal in many countries, including Türkiye.

This randomized controlled trial aims to evaluate the effect of breastfeeding education combined with a web portal and mobile application-supported breastfeeding counseling on perceived insufficient milk supply, breastfeeding intention, and breastfeeding adaptation among pregnant women.

Women at 37-39 weeks of gestation will be randomly assigned to an intervention group or a control group. Participants in the intervention group will receive individualized breastfeeding education during pregnancy, educational materials, postpartum breastfeeding support, and web portal- and mobile application-supported breastfeeding counseling. Participants in the control group will receive routine hospital care.

Data will be collected during pregnancy (baseline), immediately after birth, and at 1-, 3-, and 6-month postpartum follow-ups using validated scales assessing perceived insufficient milk supply, breastfeeding intention, and breastfeeding adaptation. Digital platform usage data, including the counseling topics accessed and the frequency of use, will also be evaluated in the intervention group.

This study is supported as a research project and aims to develop an accessible digital breastfeeding support model that may improve breastfeeding confidence, reduce perceived insufficient milk supply, and promote breastfeeding adaptation and continuation.

Read the detailed description

Breastfeeding is a critical component of maternal and infant health, providing essential nutritional, immunological, and developmental benefits for infants while supporting maternal health and well-being. Despite the established benefits of exclusive breastfeeding during the first six months of life, as recommended by the World Health Organization, many mothers experience challenges in initiating and maintaining breastfeeding. Perceived insufficient milk supply is one of the most frequently reported concerns among breastfeeding mothers and may negatively affect breastfeeding confidence, breastfeeding intention, and continuation of breastfeeding.

This randomized controlled trial aims to evaluate the effect of a breastfeeding education program combined with a web portal and mobile application-supported breastfeeding counseling on perceived insufficient milk supply, breastfeeding intention, and breastfeeding adaptation among pregnant women. The study is designed to investigate whether continuous digital support, integrated with structured prenatal breastfeeding education, can provide sustained guidance and improve breastfeeding-related outcomes during the postpartum period.

Pregnant women at 37-39 weeks of gestation will be recruited and randomly allocated to either an intervention group or a control group. Participants in the intervention group will receive individualized face-to-face breastfeeding education during pregnancy. The education will include evidence-based breastfeeding information delivered through verbal instruction, question-and-answer sessions, visual educational materials, and demonstration techniques using a newborn model. Participants will also receive a written educational booklet. Following childbirth, mothers in the intervention group will receive support during the initiation of breastfeeding and continued breastfeeding counseling through a web portal and mobile application throughout the postpartum period. Participants assigned to the control group will receive routine hospital maternity care.

Data will be collected at five assessment points: during pregnancy as a baseline assessment, immediately after childbirth during the hospital stay, and at 1-, 3-, and 6-month postpartum follow-ups. Baseline maternal characteristics will be collected using a Sociodemographic Information Form, which includes demographic, socioeconomic, health-related, and breastfeeding-related characteristics. Breastfeeding-related outcomes will be assessed using validated measurement instruments, including the Infant Feeding Intention Scale, Perceived Insufficient Milk Supply Scale, Breastfeeding Adaptation Scale, and Breastfeeding Attitude Assessment Scale. These instruments will be used to evaluate changes in mothers' breastfeeding intention, perceptions regarding milk sufficiency, breastfeeding attitudes, and adaptation to breastfeeding over the follow-up period.

In addition, digital platform engagement data will be collected for participants in the intervention group. Information regarding accessed counseling topics, frequency of platform use, and participant interactions with digital breastfeeding support services will be recorded and evaluated.

By integrating face-to-face breastfeeding education with continuous digital counseling support, this study aims to provide evidence for an accessible, sustainable breastfeeding support model. The findings may contribute to the development of evidence-based digital health interventions that support breastfeeding adaptation, address breastfeeding-related concerns, and promote breastfeeding continuation among mothers.

03

Conditions studied

  • Breastfeeding
  • Breastfeeding Attitudes
  • Breastfeeding Education
  • Breastfeeding Initiation
  • Breastfeeding Support
  • Breastfeeding Consultancy Training
  • Breastfeeding Outcomes

Browse trials for

Keywords

  • Breastfeeding education
  • Breastfeeding Counseling
  • Perception of Insufficient Milk Supply
  • Web Portal Support
  • Breastfeeding Adaptation
  • Mobile Application
04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women at 37-39 weeks of gestation.
  • Being 18 years of age or older.
  • Planning to give birth at the study hospital.
  • Planning to breastfeed their newborn.
  • Having a singleton pregnancy.
  • Having a healthy pregnancy without conditions requiring high-risk pregnancy management.
  • Being able to communicate verbally and understand the study procedures.
  • Having access to a smartphone and/or internet connection to use the web portal and mobile application (for participants assigned to the intervention group).
  • Voluntarily agreeing to participate in the study and providing written .

Exclusion criteria

Exclusion Criteria:

  • Having a medical condition that contraindicates breastfeeding.
  • Having a pregnancy complication requiring intensive medical follow-up or early delivery.
  • Multiple pregnancy (e.g., twins or higher-order pregnancies).
  • Planned cesarean delivery due to medical indications that may interfere with the breastfeeding initiation process (if applicable according to your protocol).
  • Having a newborn requiring neonatal intensive care admission after birth.
  • Previous participation in a structured breastfeeding education or digital breastfeeding counseling program during the current pregnancy.
  • Inability to complete study questionnaires or participate in follow-up assessments.
  • Not having access to the required digital tools for the intervention group.
  • Withdrawal of at any stage of the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants will receive individualized breastfeeding education during pregnancy (37-39 weeks of gestation), postpartum breastfeeding support, and web portal- and mobile application-supported breastfeeding counseling during the postpartum period.

    Behavioral: Intervention Group

  • No intervention
    Control

    Participants will receive routine maternity care provided by the hospital.

Interventions

  • BehavioralIntervention Group

    The intervention consists of a structured breastfeeding education program combined with a web portal and mobile application-supported breastfeeding counseling. Pregnant women at 37-39 weeks of gestation will receive individualized face-to-face breastfeeding education, including evidence-based breastfeeding information, question-and-answer sessions, visual educational materials, and demonstration techniques using a newborn model. Participants will also receive a written booklet on breastfeeding education. Following childbirth, participants will receive support during the initiation of breastfeeding and continuous breastfeeding counseling through a web portal and mobile application during the 6-month postpartum follow-up period. The digital platform will provide breastfeeding-related educational resources, professional guidance, and support for breastfeeding-related concerns. Usage data, including accessed topics and frequency of platform engagement, will be recorded for evaluation.

06

What researchers measure

Primary outcomes

  1. Personal information form before intervention

    Evaluation of women using personal information. This tool includes questions on women's sociodemographic characteristics

    Time frame: Day 1 (During recruitment)

  2. Perceived Insufficient Milk Supply

    Participants' perceived milk supply will be assessed using the Perceived Insufficient Milk Supply Scale. The scale evaluates mothers' perceptions regarding breast milk adequacy and concerns about insufficient milk production. Changes in perceived insufficient milk supply between the intervention and control groups will be evaluated throughout the follow-up period.

    Time frame: Baseline (during pregnancy at 37-39 weeks of gestation), and at 1-, 3-, and 6-month postpartum follow-ups

Secondary outcomes

  1. Breastfeeding Intention

    Breastfeeding intention will be assessed using the Infant Feeding Intention Scale. This measure assesses mothers' intentions regarding infant feeding practices and the planned duration of breastfeeding. Changes in breastfeeding intention between the intervention and control groups will be evaluated during the study period.

    Time frame: Baseline (during pregnancy at 37-39 weeks of gestation), and at 1-, 3-, and 6-month postpartum follow-ups

  2. Breastfeeding Adaptation

    Breastfeeding adaptation will be assessed using the Breastfeeding Adaptation Scale. This measure evaluates mothers' adaptation to the breastfeeding process, including breastfeeding-related experiences, confidence, and adjustment during the postpartum period. Changes in breastfeeding adaptation scores between the intervention and control groups will be evaluated throughout the follow-up period.

    Time frame: At 1-, 3-, and 6-month postpartum follow-ups

07

Study locations

1 of 1 sites recruiting
  • Bursa Uludag University obstetrics and gynecology clinic
    Bursa, Turkey (Türkiye)
    Recruiting
08

References and documents

Publications

  • Alus Tokat M, Sercekus P, Yenal K, Okumus H. Early postpartum breast-feeding outcomes and breast-feeding self-efficacy in Turkish mothers undergoing vaginal birth or cesarean birth with different types of anesthesia. Int J Nurs Knowl. 2015 Apr;26(2):73-9. doi: 10.1111/2047-3095.12037. Epub 2014 Jun 5. PubMed 24897921 ↗
  • Stockdale J, Sinclair M, Kernohan G, McCrum-Gardner E, Keller J. Sensitivity of the breastfeeding motivational measurement scale: a known group analysis of first time mothers. PLoS One. 2013 Dec 31;8(12):e82976. doi: 10.1371/journal.pone.0082976. eCollection 2013. PubMed 24391731 ↗
  • Li, X., Wang, Y., Chen, L., & Zhang, H. (2021). Effect of antenatal breastfeeding education on maternal breastfeeding self-efficacy and perception of milk insufficiency: A randomized controlled trial. International Breastfeeding Journal, 16(1), 55. https://doi.org/10.1186/s13006-021-00399-5
  • McCarter-Spaulding DE, Kearney MH. Parenting self-efficacy and perception of insufficient breast milk. J Obstet Gynecol Neonatal Nurs. 2001 Sep-Oct;30(5):515-22. doi: 10.1111/j.1552-6909.2001.tb01571.x. PubMed 11572532 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers. The collected data will be used only for the purposes specified in the study protocol. Participant confidentiality and data protection will be maintained in accordance with ethical requirements and applicable regulations.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Feb 2027, 7 months after the start.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 7 months is below that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2026
First posted
Jul 23, 2026
StartActual
Jul 20, 2026
Primary completionEst.
Feb 20, 2027
CompletionEst.
Feb 20, 2027
Last update
Aug 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07721311
Responsible party
Gonca Buran (Associate Professor, Aydin Adnan Menderes University) — Principal investigator
First posted
Jul 23, 2026
Start date
Jul 20, 2026
Primary completion
Feb 20, 2027 (estimated)
Completion
Feb 20, 2027 (estimated)
Last update
Aug 20, 2026

Study contacts

Gonca Buran, Assoc Prof
Contact
gburan@uludag.edu.tr
+90 2242942481
Gonca Buran, Asson Prof
study director · Uludag University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion